NovaBay Pharmaceuticals (NYSE:NBY) announced on Tuesday that it has received an unsolicited, non-binding offer from Refresh ...

NovaBay (NYSE:NBY) said it has accepted a revised offer from PRN Physician Recommended Nutriceuticals that increases the base purchase price of its Avenova eyecare business to $11.5M from $9.5M. In ...

BLUE BELL, PA — Acumen Health Holdings, LLC has announced an agreement through its subsidiary, PRN Physician Recommended ...

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that the Company’s board of directors has determined that an unsolicited and non-binding offer from Refresh ...

NovaBay (NBY) announced that the company’s board of directors has determined that an unsolicited and non-binding offer from Refresh ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

EMERYVILLE, Calif., July 30, 2024--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reports record sales of Avenova®-branded eyecare products during the Amazon Prime Day event, which was held ...

“This transaction allows our stockholders to more fully realize the value we have created over the past 10 years with the Avenova brand. We are particularly pleased to place Avenova with ...

The Brand's leading product, the Avenova® Lid & Lash Cleansing Spray, is a hypochlorous acid spray utilized to promote eye hygiene. Avenova® products are sold through the direct-to-consumer, ...

Novabay(NBY)发布Q3财报，2024财年前三财季累计收入747.20万美元，去年同期累计收入为835.40万美元，同比减少10.56%。 2024财年前三财季累计净亏损601.10万美元，去年同期累计净亏损为553.20万美元，同比扩大8.66%。 本财年累计基本每股收益为-3.97美元，去年同期为-79.58美元。 公司所属行业为制药。 Novabay Pharmaceuticals, ...

Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.